SCHEMBL7378191

SCHEMBL7378191

O=C1[C@H]2C=CCC[C@H]2C(=O)N1CCc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.53
ALDH1A1 P00352 10/20 0.52
KMT2A Q03164 4/20 0.52
MEN1 O00255 3/20 0.52
SMN1; SMN2 Q16637 2/20 0.50
CASP1 P29466 2/20 0.50
CASP7 P55210 2/20 0.50
ALOX12 P18054 1/20 0.50
GAA P10253 3/20 0.44
HTT P42858 2/20 0.44
MAPT P10636 2/20 0.44
HSD17B10 Q99714 2/20 0.44
USP2 O75604 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
GSK3A P49840 1/20 0.44
GSK3B P49841 1/20 0.44
MGLL Q99685 1/20 0.44
MAPK1 P28482 1/20 0.44
CASR P41180 2/20 0.43
CASP3 P42574 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7378193 1.00 LMNA (0.53) LMNAALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL7378192 1.00 LMNA (0.53) LMNAALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL7422455 0.86 CA1 (0.43) LMNAALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL15184112 0.78 ALDH1A1 (0.41) LMNAALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL21461267 0.78 ALDH1A1 (0.32) ALDH1A1KMT2AMEN1RAB9A
SCHEMBL8149048 0.78 ALDH1A1 (0.41) LMNAALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL1101922 0.77 ALDH1A1 (0.70) LMNAALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL7382903 0.77 ALDH1A1 (0.70) LMNAALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL7382899 0.77 ALDH1A1 (0.70) LMNAALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL7715767 0.74 CNR2 (0.41) ALDH1A1KMT2AMEN1SMN1; SMN2MGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5409929-A Treating psychosis, dyskinesia THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1995-04-25 US disclosed
WO-1993016047-A1 HYDROISOINDOLINES AND HYDROISOQUINOLINES AS PSYCHOTROPIC DRUGS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1993-08-19 WO disclosed
US-5216018-A Antidyskinetic agents DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1993-06-01 US disclosed